AKT1 and hepatocellular carcinoma: To confirm that miR-3127 upregulation promotes HCC proliferation by activating PI3K/AKT signaling, miR-3127–transfected HepG2 and QGY-7703 cells were treated with an AKT inhibitor (MK-2206) and an PI3K inhibitor (LY294002).